Identification of Fusion Transcripts in Leukеmic Cells by Whole-Transcriptome Sequencing
- Autores: Ikonnikova A.Y.1, Ammour Y.I.2, Snezhkina A.V.1, Krasnov G.S.1, Kudryavtseva A.V.1, Nasedkina T.V.1,2
-
Afiliações:
- Engelhardt Institute of Molecular Biology
- Federal Research and Clinical Center of Pediatric Hematology, Oncology, and Immunology
- Edição: Volume 52, Nº 2 (2018)
- Páginas: 200-205
- Seção: Genomics. Transcriptomics
- URL: https://journals.rcsi.science/0026-8933/article/view/163457
- DOI: https://doi.org/10.1134/S0026893318020048
- ID: 163457
Citar
Resumo
Genetic aberrations in leukemia often lead to the formation of expressed chimeric genes, which should be assessed for proper diagnosis and therapy. Modern methods of molecular diagnostic mainly allow to identify already known fusion genes. RNAseq is an efficient tool for identification of rare and novel chimeric transcripts. Here we present the results of the whole transcriptome analysis of bone marrow samples from five patients with acute myeloblastic leukemia and one, with myelodysplastic syndrome. The wholetranscriptome analysis was performed using Illumina/Solexa approach. We found rare or unknown chimeric transcripts including ETV6-MDS1, MN1-ETV6, OAZ1-PTMA, and MLLT10-GRIA4. Each of these transcripts was confirmed by RT-PCR and Sanger sequencing.
Palavras-chave
Sobre autores
A. Ikonnikova
Engelhardt Institute of Molecular Biology
Email: nased@biochip.ru
Rússia, Moscow, 119991
Yu. Ammour
Federal Research and Clinical Center of Pediatric Hematology, Oncology, and Immunology
Email: nased@biochip.ru
Rússia, Moscow, 119117
A. Snezhkina
Engelhardt Institute of Molecular Biology
Email: nased@biochip.ru
Rússia, Moscow, 119991
G. Krasnov
Engelhardt Institute of Molecular Biology
Email: nased@biochip.ru
Rússia, Moscow, 119991
A. Kudryavtseva
Engelhardt Institute of Molecular Biology
Email: nased@biochip.ru
Rússia, Moscow, 119991
T. Nasedkina
Engelhardt Institute of Molecular Biology; Federal Research and Clinical Center of Pediatric Hematology, Oncology, and Immunology
Autor responsável pela correspondência
Email: nased@biochip.ru
Rússia, Moscow, 119991; Moscow, 119117
Arquivos suplementares
